Red-mediated transposition and final release of the mini-F vector of a cloned infectious herpesvirus genome
- PMID: 19997639
- PMCID: PMC2780728
- DOI: 10.1371/journal.pone.0008178
Red-mediated transposition and final release of the mini-F vector of a cloned infectious herpesvirus genome
Abstract
Bacterial artificial chromosomes (BACs) are well-established cloning vehicles for functional genomics and for constructing targeting vectors and infectious viral DNA clones. Red-recombination-based mutagenesis techniques have enabled the manipulation of BACs in Escherichia coli without any remaining operational sequences. Here, we describe that the F-factor-derived vector sequences can be inserted into a novel position and seamlessly removed from the present location of the BAC-cloned DNA via synchronous Red-recombination in E. coli in an en passant mutagenesis-based procedure. Using this technique, the mini-F elements of a cloned infectious varicella zoster virus (VZV) genome were specifically transposed into novel positions distributed over the viral DNA to generate six different BAC variants. In comparison to the other constructs, a BAC variant with mini-F sequences directly inserted into the junction of the genomic termini resulted in highly efficient viral DNA replication-mediated spontaneous vector excision upon virus reconstitution in transfected VZV-permissive eukaryotic cells. Moreover, the derived vector-free recombinant progeny exhibited virtually indistinguishable genome properties and replication kinetics to the wild-type virus. Thus, a sequence-independent, efficient, and easy-to-apply mini-F vector transposition procedure eliminates the last hurdle to perform virtually any kind of imaginable targeted BAC modifications in E. coli. The herpesviral terminal genomic junction was identified as an optimal mini-F vector integration site for the construction of an infectious BAC, which allows the rapid generation of mutant virus without any unwanted secondary genome alterations. The novel mini-F transposition technique can be a valuable tool to optimize, repair or restructure other established BACs as well and may facilitate the development of gene therapy or vaccine vectors.
Conflict of interest statement
Figures




Similar articles
-
A self-excisable infectious bacterial artificial chromosome clone of varicella-zoster virus allows analysis of the essential tegument protein encoded by ORF9.J Virol. 2007 Dec;81(23):13200-8. doi: 10.1128/JVI.01148-07. Epub 2007 Oct 3. J Virol. 2007. PMID: 17913822 Free PMC article.
-
Cloning of the varicella-zoster virus genome as an infectious bacterial artificial chromosome in Escherichia coli.Vaccine. 2004 Sep 28;22(29-30):4069-74. doi: 10.1016/j.vaccine.2004.03.062. Vaccine. 2004. PMID: 15364458
-
Construction of a full-length infectious bacterial artificial chromosome clone of duck enteritis virus vaccine strain.Virol J. 2013 Nov 6;10:328. doi: 10.1186/1743-422X-10-328. Virol J. 2013. PMID: 24195756 Free PMC article.
-
Cloning of herpesviral genomes as bacterial artificial chromosomes.Rev Med Virol. 2003 Mar-Apr;13(2):111-21. doi: 10.1002/rmv.380. Rev Med Virol. 2003. PMID: 12627394 Review.
-
Viral bacterial artificial chromosomes: generation, mutagenesis, and removal of mini-F sequences.J Biomed Biotechnol. 2012;2012:472537. doi: 10.1155/2012/472537. Epub 2012 Feb 23. J Biomed Biotechnol. 2012. PMID: 22496607 Free PMC article. Review.
Cited by
-
Varicella zoster virus latency.Future Virol. 2011 Mar;6(3):341-355. doi: 10.2217/fvl.10.90. Future Virol. 2011. PMID: 21695042 Free PMC article.
-
Drug resistance of clinical varicella-zoster virus strains confirmed by recombinant thymidine kinase expression and by targeted resistance mutagenesis of a cloned wild-type isolate.Antimicrob Agents Chemother. 2015 May;59(5):2726-34. doi: 10.1128/AAC.05115-14. Epub 2015 Feb 23. Antimicrob Agents Chemother. 2015. PMID: 25712361 Free PMC article.
-
Bacterial artificial chromosome mutagenesis using recombineering.J Biomed Biotechnol. 2011;2011:971296. doi: 10.1155/2011/971296. Epub 2010 Dec 9. J Biomed Biotechnol. 2011. PMID: 21197472 Free PMC article. Review.
-
Varicella-zoster virus human ganglionic latency: a current summary.J Neurovirol. 2010 Nov;16(6):411-8. doi: 10.1007/BF03210846. Epub 2010 Sep 27. J Neurovirol. 2010. PMID: 20874010 Review.
-
Herpesvirus BACs: past, present, and future.J Biomed Biotechnol. 2011;2011:124595. doi: 10.1155/2011/124595. Epub 2010 Oct 27. J Biomed Biotechnol. 2011. PMID: 21048927 Free PMC article. Review.
References
-
- Shizuya H, Kouros-Mehr H. The development and applications of the bacterial artificial chromosome cloning system. Keio J Med. 2001;50:26–30. - PubMed
-
- Wagner M, Ruzsics Z, Koszinowski UH. Herpesvirus genetics has come of age. Trends Microbiol. 2002;10:318–324. - PubMed
-
- Copeland NG, Jenkins NA, Court DL. Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet. 2001;2:769–779. - PubMed
-
- Yang XW, Gong S. An overview on the generation of BAC transgenic mice for neuroscience research. Curr Protoc Neurosci, Chapter. 2005;5 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials